Search results
Aortic Atherosclerosis as a Predictor of LAA Thrombus
Added:
9 months ago
Original Research
Added:
2 years ago
ISLAA 2026
Start date:
Mar 07, 2026
End date:
Mar 06, 2026
Event
Added:
1 month ago
Dr Amr Nawar (Sultan Qaboos University Hospital, Muscat, OM) walks through a concomitant pulmonary vein isolation (PVI) and left atrial appendage (LAA) closure procedure in a single 90-minute session — treating the arrhythmia and addressing embolic risk simultaneously.The case centres on a 70-year-old male with atrial fibrillation and a history of two transient ischaemic attacks. Dr Nawar details…
View more
Added:
7 months ago
Source:
Arrhythmia Academy
For patients undergoing atrial fibrillation (AF) ablation, preprocedural thrombus screening with intracardiac echocardiography (ICE) is noninferior to the standard transoesophageal echocardiography (TEE) for preventing thromboembolic events, according to findings from a recent randomised trial.¹ The study, known as the ICE vs TEE Study (NCT05466266), also found that ICE offered benefits in…
View more
Added:
8 months ago
What are the main management recommendations from SCAI and HRS concerning left atrial appendage occlusion?In this short interview, Dr Andrew Goldsweig (Baystate Medical Center, Springfield, US) discusses the new guidelines regarding transcatheter left atrial appendage occlusion by the Society for Cardiovascular Angiography & Interventions and Heart Rhythm Society. The multidisciplinary guideline…
View more
Added:
1 year ago
AHA Conference 2024 - Five-Year safety and efficacy follow-up outcomes investigating the non-inferiority of the AMPLATZER Amulet device (Abbott Medical Devices) against the commercially available WATCHMAN (Boston Scientific) device.Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute - HCA Midwest, KS, US) joins us onsite at AHA Conference to discuss the findings from Amulet IDE …
View more
Added:
3 months ago
AF Symposium 2026 - Dr Devi Nair (St Bernards Heart & Vascular, US) joins us to discuss early outcomes from the VERITAS Study, evaluating Abbott's next-generation Amulet 360™ Left Atrial Appendage Occluder for stroke prevention in patients with non-valvular atrial fibrillation.This pivotal study enrolled 400 patients across 34 centers in the United States, Canada, and Europe. Findings presented…
View more
Added:
1 year ago
How can a causal machine learning framework act as a decision-supporting tool to select patients for left atrial appendage occlusion (LAAO)?In this short interview, Dr Xiaoxi Yao (Mayo Clinic, Rochester, MN, US) discusses a study investigating the causal forest model learning framework to identify characteristics in atrial fibrillation patients which would benefit most from LAAO. Dr Yao explains…
View more
T Wave Oversensing in LOT-CRT
Added:
22 hours ago
Case Report